In Regard to Wang et al on Long-term Outcomes Following D2 Gastrectomy for Early Gastric Cancer

  • Tang, Weng Heng (Clinical Oncology, Medicine, University of Malaya Medical Centre)
  • Published : 2015.04.14




  1. Freedberg DE, Abrams JA, Wang TC (2014). Prevention of gastric cancer with antibiotics: can it be done without eradicating Helicobacter pylori? J Natl Cancer Inst, 106, 148
  2. Kwon YH, Heo J, Lee HS, Cho CM, Jeon SW (2014). Failure of Helicobacter pylori eradication and age are independent risk factors for recurrent neoplasia after endoscopic resection of early gastric cancer in 283 patients. Alimentary Pharmacology Therapeutics, 39, 609-18.
  3. Li WQ, Ma JL, Zhang L, et al (2014). Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups. J Natl Cancer Inst, 106, 116.
  4. NCCN Clinical Practice Guideline on Gastric Cancer v1.2014. (Accessed on October 12, 2014).
  5. Okada K, Fujisaki J, Yoshida T, et al (2012). Long-term outcomes of endoscopic submucosal dissection for undifferentiatedtype early gastric cancer. Endoscopy, 44, 122-7.
  6. Wang Z, Ma L, Zhang XM, Zhou ZX (2014). Long-term outcomes after D2 gastrectomy for early gastric cancer: survival analysis of a single-center experience in China. Asian Pac J Cancer Prev, 15, 7219-7222.
  7. Wong BCY, Lam SK, Wong WM, et al (2004). Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA, 291,